Title : Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate.

Pub. Date : 2019

PMID : 28460618






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate. Idarubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 OBJECTIVE: In the current study, HER2-specific affibody molecule, ZHER2:342 (an engineered protein with great affinity for HER2 receptors) was selected for conjugation to idarubicin (an anti-neoplastic antibiotic). Idarubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 OBJECTIVE: In the current study, HER2-specific affibody molecule, ZHER2:342 (an engineered protein with great affinity for HER2 receptors) was selected for conjugation to idarubicin (an anti-neoplastic antibiotic). Idarubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens